Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: Clinical and haematological characteristics of 23 patients

Annals of the Rheumatic Diseases

Volumn 64, Issue 6, 2005, Pages 943-946

  Asherson, R A ^a   Espinosa, G ^b   Cervera, Ricard ^b   Gomez Puerta J A ^b   Musuruana, J ^b   Bucciarelli, S ^b   Ramos Casals, M ^b   Martinez Gonzalez A L ^b   Ingelmo, M ^b   Reverter, J C ^b   Font, J ^b   Triplett, D A ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b HOSPITAL CLÍNIC   (Spain)

^c BALL STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; CARDIOLIPIN ANTIBODY; CYCLOPHOSPHAMIDE; D DIMER; FIBRINOGEN; FIBRINOGEN DEGRADATION PRODUCT; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROSTACYCLIN; STEROID;

ADOLESCENT; ADULT; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL LABORATORY; DIFFERENTIAL DIAGNOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HUMAN; LABORATORY TEST; MALE; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROTHROMBIN TIME; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOEMBOLISM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIPHOSPHOLIPID SYNDROME; CHILD; DIAGNOSIS, DIFFERENTIAL; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; REGISTRIES; TREATMENT OUTCOME;

EID: 21144442653     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.026377     Document Type: Article

References (15)

1. Levi M, de Jonge E, van der Poll T, ten Cate H. Advances in the understanding of the pathogenetic pathways of disseminated intravascular coagulation result in more insight in the clinical picture and better management strategies. Semin Thromb Hemost 2001;27:569-75.
2. Levi M, ten Gate H. Disseminated intravascular coagulation. N Engl J Med 1999;341:586-92.
3. Muller-Berghaus G, ten Cate H, Levi M. Disseminated intravascular coagulation: clinical spectrum and established as well as new diagnostic approaches. Thromb Haemost 1999;82:706-12.
4. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol 1992;19:508-12.
5. Cervera R, Piette J-C, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002;46:1019-27.
6. Asherson RA, Cervera R, de Groot PG, Erkan D, Boffa M-C, Piette J-C, et al. Catastrophic antiphospholipid syndrome: international consensus statement an classification criteria and treatment guidelines. Lupus 2003;12:530-4.
7. Asherson RA, Cervera R, Piette J-C, Font J, Lie JT, Burcoglu A, et al. Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998;77:195-207.
8. Asherson RA, Cervera R, Piette J-C, Shoenfeld Y, Espinosa G, Petri MA, et al. Catastrophic antiphospholipid syndrome. Clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 2001;80:355-77.
9. Cervera R, Gomez-Puerta JA, Espinosa G, Cucho M, Font J. "CAPS registry": a review of 200 cases from the international registry of patients with catastrophic antiphospholipid syndrome (CAPS). Ann Rheum Dis 2003;62(suppl 1):88.
10. Taylor FB, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001;86:1327-30.
11. Triplett DA, Asherson RA. Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS). Am J Hematol 2000;65:154-9.
12. De Groot PG, Horbach DA, Derksen RHWM. Protein C and other cofactors involved in the binding of antiphospholipid antibodies: relation to the pathogenesis of thrombosis. Lupus 1996;5:488-93.
13. Tassies D, Espinosa G, Munoz-Rodriguez FJ, Freire C, Cervera R, Monteagudo J, et al. The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome. Arthritis Rheum 2000;43:2349-58.
14. McKay DG. Diseases of hypersensitivity: disseminated intravascular coogulation. Arch Intern Med 1965;116:83-94.
15. Asherson RA, Shoenfeld Y. The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome - molecular mimicry? J Rheumatol 2000;27:12-14.